Chinese gene therapy company Gritgen Therapeutics has announced the launch of operations at its commercial GMP facility in Suzhou Industrial Park. 18 October 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.